Ocugen (OCGN) Net Income (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.69% |
| Dec 31, 2025 | 2.81% |
| Sep 30, 2025 | -26.12% |
| Jun 30, 2025 | 3.91% |
| Mar 31, 2025 | -10.15% |
| Dec 31, 2024 | -8.19% |
| Sep 30, 2024 | 15.09% |
| Jun 30, 2024 | -28.22% |
| Mar 31, 2024 | -3.38% |
| Dec 31, 2023 | 7.29% |
| Sep 30, 2023 | 47.19% |
| Jun 30, 2023 | -30.52% |
| Mar 31, 2023 | 17.79% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -1.60% |
| Jun 30, 2022 | -13.38% |
| Mar 31, 2022 | -30.51% |
| Dec 31, 2021 | -35.57% |
| Sep 30, 2021 | 58.02% |
| Jun 30, 2021 | -262.02% |
| Mar 31, 2021 | -87.82% |
| Dec 31, 2020 | 64.03% |
| Sep 30, 2020 | -189.82% |
| Jun 30, 2020 | 8.36% |
| Mar 31, 2020 | 8.16% |
| Dec 31, 2019 | -22.35% |
| Sep 30, 2019 | -35.53% |
| Jun 30, 2019 | 53.22% |
| Mar 31, 2019 | 13.54% |
| Dec 31, 2018 | -88.20% |
| Sep 30, 2018 | 53.09% |
| Jun 30, 2018 | -19.75% |
| Mar 31, 2018 | -0.72% |
| Dec 31, 2017 | -5.97% |
| Sep 30, 2017 | 10.42% |
| Jun 30, 2017 | 6.78% |
| Mar 31, 2017 | 14.16% |
| Dec 31, 2016 | -18.36% |
| Sep 30, 2016 | 16.28% |
| Jun 30, 2016 | -1.95% |
| Mar 31, 2016 | 6.00% |
| Dec 31, 2015 | -3.40% |
| Sep 30, 2015 | -5.81% |
| Jun 30, 2015 | 3.98% |
| Mar 31, 2015 | -18.95% |
| Dec 31, 2014 | 55.40% |
| Sep 30, 2014 | -148.90% |
| Jun 30, 2014 | -16.18% |